AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AEVIS VICTORIA SA

Investor Presentation May 12, 2015

808_ip_2015-05-12_615b1888-1b9b-450a-9812-13e8eee4562d.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

AEVISCompany Presentation

May 2015

Disclaimer

This communication contains statements that constitute "forward‐looking statements". In this communication, such forward‐looking statements include, without limitation, statements relating to our financial condition, results of operations and business and certain of our strategic plans and objectives. Because these forward‐looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors which are beyond AEVIS Holding SA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors detailed in AEVIS Holding SA's past and future filings and reports and in past and future filings, press releases, reports and other information posted on AEVIS' group companies websites. Readers are cautioned not to put undue reliance on forward‐looking statements, which speak only of the date of this communication. AEVIS Holding disclaims any intention or obligation to update and revise any forward‐looking statements, whether as a result of new information, future events or otherwise. This presentation does not constitute an offer tosell or a solicitation to purchase any securities of AEVIS Holding SA.

AEVIS – valuecreation through acquisitions

  • • Since2010, strong expansion of P&L and balance sheet thanks to internal and external growth
  • • In 2015, expected pro forma revenue of approximately CHF 600m (all entities consolidated over a 12‐monthperiod) and an improvement of profitability of 1.5% to 3.0%

Highlights and outlook

i
S
t
t
r
a
e
g
c
l
i
t
m
e
s
o
n
e
s
2
0
1
4
f
(
"G
")
f
h
l
i
i
d
i
l
k
l
l
G
G
S
M
N
S
A
S
M
N
t
t
t
t

r
o
w
s
r
a
e
g
y
o
e
n
o
e
r
w
s
s
e
c
a
e
w
o
r
s
u
c
c
e
s
s
u
y
h
d
h
h
f
h
t
l
i
i
i
i
1
i
i
5
t
t
t
t
t
t
c
o
n
n
u
e
w
e
n
e
g
r
a
o
n
o
e
c
n
c
d
h
f
l
h
(
"S
")
i
i
i
I
S
H
P
A
G
H
P
t
t
t
t
t
t
t

n
e
g
r
a
o
n
a
n
g
r
o
w
s
r
a
e
g
y
o
w
s
s
e
a
c
a
r
e
r
o
p
e
r
e
s
(
),
i
i
h
h
i
i
f
h
b
i
l
d
i
f
i
k
l
i
k
i
l
l
i
k
h
i
P
V
P
R
t
t
t
t
t
t
t
t
p
r
o
r
e
s
s
n
e
n
e
r
a
o
n
o
e
n
s
o
r
a
n
a
m
a
r
o
r
s
g
g
w
g
u
g
v
l
f
(
)
d
l
l
i
i
i
i
i
i
A
G
S
C
C
I
C
C
t
t
r
a
c
e
r
n
r
a
s
r
u
c
u
r
e
o
n
a
n
n
c
a
r
e
n
s
i
i
f
i
i
f
f
l
l
i
l
d
i
h
h
b
l
i
k
f
D
A
E
V
I
S
t
t
t
t
t
t
t

e
r
s
c
a
o
n
s
r
a
e
g
o
s
c
c
e
s
s
m
p
e
m
e
n
e
e
p
c
a
e
o
e
r
o
v
y
u
u
y
w
u
v
f
h
h
f
f
l
l
(
"V
")
2
%
i
i
i
G
7
1.
V
J
C
A
J
C
t
t
t
o
e
s
a
r
e
s
o
c
o
r
a‐
u
n
g
r
a
u
o
e
c
o
n
l
i
i
F
n
a
n
c
a
h
i
h
l
i
h
2
0
1
4
t
g
g
s
d
b
l
l
i
9.
2
%
C
2.
i
i
T
1
H
F
5
4
4
t

u
r
n
o
v
e
r
n
c
r
e
a
s
e
y
o
m
o
n
f
d
i
l
l
i
E
B
I
T
D
A
C
H
F
6
5.
4
1
2.
1
%
t

s
o
a
r
e
o
m
o
n
o
r
o
r
e
v
e
n
u
e
s
(
)
f
l
i
d
i
f
h
i
d
i
h
b
d
i
l
l
i
S
A
E
V
I
S
5‐
C
H
F
1
4
5
t
t
t

c
c
e
s
s
s
s
e
a
n
n
c
r
e
a
s
e
o
a
r
s
r
a
o
n
e
a
r,
m
o
n
u
u
u
g
y
F
o
c
u
s
2
0
1
5
h
d
l
f
'
f
"s
f
b
l
f
"
i
i
i
F
A
E
V
I
S
t
t
t
t
t
t

u
r
e
r
e
v
e
o
p
m
e
n
o
n
v
e
s
m
e
n
o
c
u
s
o
n
e
r
v
c
e
s
o
r
a
e
e
r
e
l
l
i
i
i
i
l
i
f
d
F
G
S
M
N
S
H
P
t

a
c
q
s
o
n
p
p
e
n
e
o
r
a
n
u
u
f
i
i
i
C
R
V
J
t

e‐
p
o
s
o
n
n
g
o
l
l
(
f
h
)
d
i
i
d
2
0
1
5
C
H
F
6
0
0
1
2‐
t
t
t
t

r
e
v
e
n
u
e
a
r
g
e
e
a
a
p
p
r
o
x.
m
o
n
p
r
o
o
r
m
a
a
n
o
v
e
r
m
o
n
s
i
i
f
i
i
i
i
i
b
F
E
B
I
T
D
A
1.
5
%
3.
0
%
t
t
t
t

o
c
s
o
n
m
p
r
o
n
g
o
e
s
n
g
a
c
e
s
o
u
v
x
v
y

AEVISkey financials

i
h
d
C
H
F
t
n
o
u
s
a
n
2
0
1
1
2
0
1
2
2
0
1
3
2
0
1
4
2
0
1
5
F
f
i
&
K
P
L
e
y
g
u
r
e
s
l
T
t
o
a
r
e
v
e
n
u
e
'8
2
0
0
1
8
'4
3
4
4
0
6
'6
4
5
4
6
9
'3
5
4
2
7
2
'0
6
0
0
0
0
h
t
g
ro
w
4.
4
%
7
1.
5
%
3
2.
0
%
1
9.
3
%
1
0.
6
%
E
B
I
T
D
A
'0
2
4
2
6
'9
3
9
6
8
'7
6
0
5
5
'4
6
5
0
3
E
B
I
T
D
A
in
m
ar
g
1
1.
9
%
1
1.
6
%
1
3.
4
%
1
2.
1
%
E
B
I
T
'2
8
3
5
'7
1
6
1
4
'9
2
6
2
7
'0
2
8
9
1
in
E
B
I
T
m
ar
g
%
4.
1
%
4.
9
%
5.
9
%
5.
2
f
b
l
h
i
K
t
e
y
g
u
r
e
s
a
a
n
c
e
s
e
e
l
T
t
t
o
a
a
s
s
e
s
'8
1
7
6
8
3
'4
7
3
4
4
8
'0
'6
1
0
5
5
7
'2
'6
1
8
8
0
4
l
l
i
b
i
l
i
i
T
t
t
o
a
a
e
s
'0
1
4
3
3
6
'9
5
7
2
0
8
'7
7
7
2
3
8
'4
9
6
9
0
2
l
i
T
t
t
o
a
e
q
u
y
'8
3
3
4
7
'5
1
6
1
4
0
'9
2
3
2
1
9
'2
3
1
9
0
2
i
io
ty
t
eq
u
ra
%
1
9.
1
%
2
2.
0
%
2
3.
2
%
2
4.
8
  • • AEVIS' revenue is well diversified combining the stable and regulated healthcare activity of GSMNand related entities and the hospitality and lifestyle activity of VJC
  • • AEVIS balance sheet is real estate heavy owning many of its clinic and hotel buildings to be able toprovide stability for further growth
  • • Nogoodwill on the balance sheet

AEVIS Annual Results 2014– balance sheet

'0
C
0
0
I
H
F
n
3
2.
2
0
1.
1
1
4
3
2.
2
0
3
1.
1
1
h
d
h
i
l
C
t
a
s
a
n
c
a
s
e
q
u
v
a
e
n
s
'5
4
8
7
4
'0
2
9
6
5
h
O
t
t
t
e
r
c
r
r
e
n
a
s
s
e
s
u
'7
8
0
0
1
7
'1
8
1
5
1
4
l
T
t
t
t
o
a
c
u
r
r
e
n
a
s
s
e
s
'2
2
2
7
7
4
'1
1
8
7
7
9
d
i
F
t
x
e
a
s
s
e
s
'0
'2
3
8
1
1
5
'3
8
2
2
3
7
h
O
t
t
t
e
r
n
o
n‐
c
u
r
r
e
n
a
s
s
e
s
'0
4
6
9
2
'1
3
6
5
5
l
T
t
t
t
o
a
n
o
n‐
c
u
r
r
e
n
a
s
s
e
s
'0
'3
1
6
1
3
0
'4
8
1
8
7
8
l
T
t
t
o
a
a
s
s
e
s
'2
'6
1
8
8
0
4
'0
'6
1
0
5
5
7
h
f
l
l
b
l
S
i
i
i
i
i
i
t‐
t
t
o
r
e
r
m
n
a
n
c
a
a
e
s
'9
1
3
8
6
7
'6
2
1
1
6
7
h
l
b
l
O
i
i
i
i
t
t
t
e
r
c
u
r
r
e
n
a
e
s
'9
1
2
1
6
6
'7
1
2
2
6
3
l
l
i
b
i
l
i
i
T
t
t
t
o
a
c
u
r
r
e
n
a
e
s
'9
2
5
9
5
2
'4
3
3
4
3
0
f
l
l
b
l
L
i
i
i
i
i
i
‐t
t
o
n
g
e
r
m
n
a
n
c
a
a
e
s
'6
5
7
8
2
2
'5
3
4
4
7
3
h
l
b
l
O
i
i
i
i
t
t
t
e
r
n
o
n‐
c
u
r
r
e
n
a
e
s
'8
1
3
0
2
8
'7
9
3
3
5
l
l
i
b
i
l
i
i
T
t
t
t
o
a
n
o
n‐
c
r
r
e
n
a
e
s
u
'4
7
0
9
5
0
'3
4
3
8
0
8
l
l
i
b
i
l
i
i
T
t
t
o
a
a
e
s
'4
9
6
9
0
2
'7
7
7
2
3
8
l
i
T
t
t
o
a
e
q
u
y
'2
3
1
9
0
2
'9
2
3
2
1
9
l
d
l
b
l
i
i
i
i
i
T
t
t
t
o
a
e
q
u
y
a
n
a
e
s
'2
'6
8
8
0
1
4
'0
'6
0
1
5
5
7
  • Asset base in excess of CHF 1.28 billion thanks to the acquisition of VJC and Villa im Parkreal estate
  • Netfinancial leverage of 53.23%
  • Half of financial debt is real‐estatebacked(mortgages)
  • Increased equity and further improvement of equity ratio to 24.8%(23.2% at 31.12.2013)
  • Nogoodwill on the balance sheet
  • Significant financing reserves to fund AEVIS' continued growth strategy

AEVIS Annual Results 2014– income statement

'0
I
C
H
F
0
0
n
2
0
1
4
2
0
1
3
R '3
5
4
2
7
2
'6
4
5
4
6
9
e
e
n
e
v
u
h
t
g
ro
w
1
9.
3
%
n.
a.
O
i
t
p
e
r
a
n
g
e
x
p
e
n
s
e
s
(
)
'4
4
1
9
8
4
(
)
'6
3
4
1
9
7
E
B
I
T
D
A
'4
6
5
0
3
'7
6
0
5
5
in
m
ar
g
1
2.
1
%
1
3.
4
%
d
D
i
i
i
i
t
t
t
e
p
r
e
c
a
o
n
a
n
a
m
o
r
s
a
o
n
(
'7
)
3
3
3
3
(
'8
)
3
3
2
8
E
B
I
T
'0
2
8
9
1
'9
2
6
2
7
in
m
ar
g
5.
2
%
5.
9
%
l
l
F
i
i
t
n
a
n
c
a
r
e
s
u
(
'5
)
2
0
0
2
(
'3
)
1
5
2
5
h
f
l
f
S
i
t
a
r
e
o
o
s
s
o
e
q
u
y
2
1
4
(
)
6
1
1
d
i
t
t
a
o
n
e
n
e
s
e
e
s
c
c
u
v
d
l
O
i
t
r
n
a
r
y
r
e
s
u
'8
0
3
7
'4
1
1
4
1
d
l
E
i
t
t
x
r
a
o
r
n
a
r
y
r
e
s
u
(
'4
)
1
1
6
(
)
1
2
3
i
b
f
E
t
a
r
n
n
g
s
e
o
r
e
a
x
e
s
'3
6
8
7
'3
1
1
1
8
I
t
n
c
o
m
e
a
x
e
s
(
)
1
3
8
(
)
'3
4
4
1
f
i
f
h
P
t
t
r
o
o
r
e
y
e
a
r
'1
6
1
8
'6
8
7
5
in
m
ar
g
1.
1
%
1.
9
%
  • Strong revenue growth (+19.3%) through targeted acquisitions
  • Slight decrease in EBITDA margin at 12.1%, due to the integration of newacquisitions
  • Depreciation mostly based on SHP growth and VJC integration
  • Increased financial charges due to the bondAEV14
  • Profit for the period at CHF 6.1million

High visibility on capital markets

AEVIS is listedon the Domestic Standard of SIX Swiss Exchange (Ticker: AEVS)

  • • Stock price 30.04.2015: CHF45.75
  • • 60dVWAP: CHF 44.19
  • • Current market cap: CHF 647.8million

Todiversify its financing sources, AEVIS has successfully issued three straight bonds:

  • • 2012: CHF 80 million at 4.25%maturing in 2016
  • • 2013: CHF 100 million at 3.50%maturing in 2018
  • • 2014: CHF 145 million at 2.75%maturing in 2019

Leading healthcare and hotel platform strategy

  • • AEVIS is aninvestment company focusing on "services for a better life"
  • • GSMN with 15 private clinics in Switzerland is an important player in a heavily regulated market andaligned to participate in the shaping of the Swiss healthcare market development
  • • VJC is the largest 5* hotel group in Switzerland. The group pursues a targeted growth strategy toincrease market coverage and improve the power of the hotel brands
  • •Strong real‐estate portfolio to provide a solid foundation to GSMN and VJC

AEVIScorporate governance

AEVISfinancial and legal expertiseBoard: C. Wenger, R. Loretan, A. Hubert, M. Reybier, A. Kohler, C. GeorgeManagement: A. Hubert, G. Frachon, P‐O. Haenni, M. Blaser, S. Van der Schueren GSMNhealthcare expertise & political leverageBoard: R. Loretan, P. Glasson, M. Reybier, A. Hubert, A. Kohler, C. Le Dorze, C. George, F. PelliComex: R. Loretan, A. Hubert, B. Röthlisberger, V. Dubois‐HéquetManagement: N. Castelli, R. Boichat, P. Fabrizio, B. Siclet, B. Zambaz VJChotel expertiseBoard: C. Seiler, M. Reybier, B. Sigg, M. Ineichen, R. Loretan, A. Kohler, A. HubertComex: M. Reybier, A. Hubert, B. Sigg, R. FinanManagement: B. Sigg, P. Bachmann SHPhealthcare and real‐ estate expertiseBoard: A. Hubert, M. Reybier, G. Frachon, C. SyzManagement: C. Syz, V. Moreau

Genolier Swiss Medical Network SA(GSMN)

  • • GSMN is the 2nd largest network of private clinics in Switzerland, present in all 3 linguistic regions
  • Strong player in the private healthcare sector inSwitzerland
  • Reliable private alternative to the public healthcaresystem
  • Leader for medical tourists in Switzerland
  • • GSMN operational key figures
  • 15 private clinics and one affiliated clinic
  • More than 950 beds
  • Around 2'750 employees
  • Around 1'250 admitting physicians
  • More than 36'000 surgical interventions
  • Around 2'600 deliveries per year
  • • GSMN is managed by an experienced team with an outstanding track record and a broad network in the Swiss private Healthcare industry (with doctors, health insurers, health officials, etc.)

Victoria‐Jungfrau Collection AG (VJC)

  • • VJC is the leading luxury hotel group comprising four 5‐stars hotels in Swiss prime locations Zurich, Bern, Lucerne and Interlaken
  • • AEVISacquired 71.2% of VJC in April 2014
  • • The acquisition was a diversification move to consolidate AEVIS' strategic focus on services for abetter live
  • • With the related hotels of Michel Reybier and Seiler Hotels in Zermatt the hotel network of AEVIS extends to 8 upscale hotels in Switzerland and2 in France
  • • Strategy:
  • Integration as stand‐alone division in AEVIS
  • Growth strategy investing in existing hotels
  • Focus on improved brand positioning
  • Interlace Nescens in the hotel offerings to lever thehealthcare network of GSMN
  • Build synergies with Michel Reybier Hotel Collection and Seiler Hotels Zermatt which areall under the same general management
l
H
t
o
e
s
R
o
o
m
s
l
f
T
t
o
a
s
r
a
c
e
u
l
E
m
p
o
e
e
s
y
f
*
i
i
V
J
t
c
o
r
a‐
u
n
g
r
a
u
2
2
4
'2
4
4
6
9
2
4
3
l
P
L
a
a
c
e
u
z
e
r
n
1
2
9
'3
3
3
7
1
1
0
d
*
E
L
e
n
a
u
a
c
0
5
'4
1
1
9
5
5
l
l
l
B
P
e
e
v
u
e
a
a
c
e
1
2
8
'2
3
9
6
1
2
9
l
T
t
o
a
5
3
1
'3
5
2
2
1
5
3
7

*Buildings fully owned by VJC

Nescens

  • • Nescens offers innovative products and services for a better living / better aging connecting healthcare, wellness and lifestyle under a Swiss high quality brand
  • • Nescens is applied within GSMN's clinics as well as withinVJC's and the other affiliated hotels
  • • Integrated approach combining preventive medicine, wellness and anti‐aging medicine as well as aesthetic medicine andcosmeceuticals
  • • Emerging market segment with high growth potential, both in Switzerland and abroad
  • • Nescens divisions:
  • Centers for Preventive Medicine (Genolier, Lausanne, Lugano & Zurich (2016))
  • Swiss StemCell Science – Stem Cell banking
  • Better Aging Spas (La Réserve, VJC)
  • Paris Spontini plastic surgery clinic
  • Private Patient Units international offering of comprehensive private department packages forhospitals
  • Swiss Anti‐aging Science Cosmeceuticals

Swiss Healthcare Properties AG (SHP)

  • • SHP is a real estate company focusing on investments in healthcare related properties all overSwitzerland
  • • Today, SHP owns 28 healthcare properties, located all over Switzerland in 12 specific sites and representing a total rental surface of over 120'000m2
  • • Almost all SHP properties are rented to the various GSMN clinics, and have been bought or constructed in the context of the development of the GSMNgroup
  • • SHP is committed on the long‐term to the growth anddevelopment of the clinics' operations
  • • All SHP's properties are fully let and include an additional development potential of 15'000m2 to 20'000m2
  • • SHPwas integrated into AEVIS in July 2012
  • • SHP is managed by Patrimonium Healthcare Property Advisors AG with Christoph Syz as CEO

SHPportfolio key figures

  • • Healthcare properties 28 (12 sites) • Rental area 120'480m2• Global plot area 189'897m2 • Vacancy rate Full utilisation • LTV ratio 47.3%• Portfolio market value CHF 701.8 million • Annual rental income (2014) CHF 31.7 million • Gross yield 5.36% • Average rental income / m2 CHF 303 • Market value / rental area average CHF 5'825 •Development potential 15'000m2 to 20'000m2

AEVIS– Outlook 2015

  • Revenue forecast 2015 of approximately CHF 600 million (pro forma, all entities consolidatedover a 12‐month period, including VJC)
  • AEVIS will focus on continuing the growth strategy of GSMN and evaluate further opportunities in the healthcare related real estate market
  • AEVISwill integrate VJC and further develop the hotel and hotel‐related activities
  • AEVISplans to invest in complementary activities supporting its overall strategy
  • AEVIS focuses onimproving the EBITDA of its entities by 1.5% to 3% per year
  • In the mid‐term, AEVIS expects to realise an EBITDA of more than 20%
  • •Optimisation of its existing facilities
  • • Diversificationof its activities
  • AEVISplans to maintain its distribution policy to shareholders

Talk to a Data Expert

Have a question? We'll get back to you promptly.